Join to View Full Profile
A.I. Dupont Hospital For Children1600 Rockland RoadWilmington, DE 19803
Phone+1 302-651-4000
Fax+1 302-651-4945
Join Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Suba Krishnan, MD is a pediatric hematologist/oncologist in Wilmington, Delaware.
Education & Training
New York Presbyterian Hospital (Cornell Campus)Fellowship, Pediatric Hematology/Oncology, 1996 - 1999
Children's Hospital of MichiganResidency, Pediatrics, 1993 - 1996
ArMed Forces Medical College PuneClass of 1986
Publications & Presentations
PubMed
- 69 citationsTreatment with pembrolizumab in programmed death ligand 1-positive recurrent glioblastoma: Results from the multicohort phase 1 KEYNOTE-028 trial.David A. Reardon, Tae Min Kim, Jean-Sebastien Frenel, Matteo Simonelli, Juanita Lopez
Cancer. 2021-05-15 - 325 citationsEfficacy and Safety of Pembrolizumab for the Treatment of Advanced Biliary Cancer: Results From the KEYNOTE-158 and KEYNOTE-028 StudiesSarina Anne Piha-Paul, Do Youn Oh, Makoto Ueno, David Malka, Hyun Cheol Chung
International Journal of Cancer. 2020-10-15 - 232 citationsPembrolizumab After Two or More Lines of Previous Therapy in Patients With Recurrent or Metastatic SCLC: Results From the KEYNOTE-028 and KEYNOTE-158 Studies.Hyun Cheol Chung, Sarina Anne Piha-Paul, Jose A. Lopez-Martin, Jan H.M. Schellens, Steven Kao
Journal of Thoracic Oncology. 2020-04-01
Press Mentions
Jeffrey Hatfield Takes over from Diego Miralles as CEO of Vividion; Dragonfly Scores a New Exec with COO Alex LugovskoyNovember 25th, 2020
Mereo BioPharma Appoints Suba Krishnan, M.D. As Senior Vice President of Clinical DevelopmentNovember 23rd, 2020
